Last 12 months
Inside the activity.
0 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 7 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 13 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 19, 2025 Filed Dec 22, 2025 22:00 UTC |
Michaelson JenniferChief Scientific Officer
|
SaleCommon Stock | 1,345 | $10.01 | $13,463.45 |
DisclosureSEC source: 0001193125-25-328909 · ownership.xml · nonDerivative · entry 1 Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 132,635 F1 · kind: Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.99 to $10.09. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 18, 2025 Filed Dec 19, 2025 22:00 UTC |
SUMER JACQUELYN LChief Legal Officer
|
SaleCommon Stock | 3,480 | $9.67 | $33,651.60 |
DisclosureSEC source: 0001193125-25-327033 · ownership.xml · nonDerivative · entry 1 SUMER JACQUELYN L · CIK 0001844824 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,432 F1 · kind: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units. F2 · balance_after: Includes 2,017 shares of common stock that the Reporting Person purchased pursuant to the Issuer's 2021 Employee Stock Purchase Plan for the purchase period of January 1, 2025 through June 30, 2025 that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 18, 2025 Filed Dec 19, 2025 22:00 UTC |
Jones Jeffrey AlanChief Medical Officer
|
SaleCommon Stock | 4,632 | $9.67 | $44,791.44 |
DisclosureSEC source: 0001193125-25-327030 · ownership.xml · nonDerivative · entry 1 Jones Jeffrey Alan · CIK 0001914647 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,532 F1 · kind: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units. Read SEC document |
| December 18, 2025 Filed Dec 19, 2025 22:00 UTC |
Michaelson JenniferChief Scientific Officer
|
SaleCommon Stock | 2,898 | $9.67 | $28,023.66 |
DisclosureSEC source: 0001193125-25-327027 · ownership.xml · nonDerivative · entry 1 Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,980 F1 · kind: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units. Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 22:00 UTC |
Michaelson JenniferChief Scientific Officer
|
SaleCommon Stock | 995 | $11.90 | $11,840.50 |
DisclosureSEC source: 0001193125-25-321122 · ownership.xml · nonDerivative · entry 2 Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 136,878 F3 · kind: Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 22:00 UTC |
Michaelson JenniferChief Scientific Officer
|
SaleCommon Stock | 2,148 | $12.38 | $26,592.24 |
DisclosureSEC source: 0001193125-25-321122 · ownership.xml · nonDerivative · entry 1 Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 137,873 F1 · kind: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units. F2 · balance_after: Includes 2,017 shares of common stock that the Reporting Person purchased pursuant to the Issuer's 2021 Employee Stock Purchase Plan for the purchase period of January 1, 2025 through June 30, 2025 that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| November 24, 2025 Filed Nov 25, 2025 22:00 UTC |
Michaelson JenniferChief Scientific Officer
|
SaleCommon Stock | 4,000 | $12.30 | $49,200.00 |
DisclosureSEC source: 0001193125-25-297549 · ownership.xml · nonDerivative · entry 1 Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 138,004 F1 · kind: Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025. Read SEC document |
| October 28, 2025 Filed Oct 30, 2025 21:13 UTC |
Lynx1 Capital Management LP10% owner
Nichols Weston10% owner
|
PurchaseCommon stock, $0.0001 par value per share | 165,667 | $8.40 | $1,391,685.63 |
DisclosureSEC source: 0000902664-25-004662 · ownership.xml · nonDerivative · entry 1 Lynx1 Capital Management LP · CIK 0001910456 · 10% owner Nichols Weston · CIK 0001746376 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 8,963,500 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.035 to $8.50 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. F2 · ownership.nature: The securities to which this filing relates are held directly by Lynx1 Master Fund LP to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| October 17, 2025 Filed Oct 21, 2025 23:00 UTC |
Lynx1 Capital Management LP10% owner
Nichols Weston10% owner
|
PurchaseCommon Stock | 32,217 | $7.84 | $252,565.17 |
DisclosureSEC source: 0000902664-25-004499 · ownership.xml · nonDerivative · entry 4 Lynx1 Capital Management LP · CIK 0001910456 · 10% owner Nichols Weston · CIK 0001746376 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 8,797,833 F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.78 to $7.85 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. F2 · ownership.nature: The securities to which this filing relates are held directly by Lynx1 Master Fund LP to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| October 16, 2025 Filed Oct 21, 2025 23:00 UTC |
Lynx1 Capital Management LP10% owner
Nichols Weston10% owner
|
PurchaseCommon Stock | 150,000 | $8.86 | $1,328,250.00 |
DisclosureSEC source: 0000902664-25-004499 · ownership.xml · nonDerivative · entry 3 Lynx1 Capital Management LP · CIK 0001910456 · 10% owner Nichols Weston · CIK 0001746376 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 8,765,616 F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.68 to $9.22 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. F2 · ownership.nature: The securities to which this filing relates are held directly by Lynx1 Master Fund LP to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| October 15, 2025 Filed Oct 21, 2025 23:00 UTC |
Lynx1 Capital Management LP10% owner
Nichols Weston10% owner
|
PurchaseCommon Stock | 51,500 | $7.94 | $409,049.05 |
DisclosureSEC source: 0000902664-25-004499 · ownership.xml · nonDerivative · entry 2 Lynx1 Capital Management LP · CIK 0001910456 · 10% owner Nichols Weston · CIK 0001746376 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 8,615,616 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.88 to $8.00 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. F2 · ownership.nature: The securities to which this filing relates are held directly by Lynx1 Master Fund LP to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| October 14, 2025 Filed Oct 21, 2025 23:00 UTC |
Lynx1 Capital Management LP10% owner
Nichols Weston10% owner
|
PurchaseCommon stock, $0.0001 par value per share ("Common Stock") | 15,032 | $7.59 | $114,047.78 |
DisclosureSEC source: 0000902664-25-004499 · ownership.xml · nonDerivative · entry 1 Lynx1 Capital Management LP · CIK 0001910456 · 10% owner Nichols Weston · CIK 0001746376 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 8,564,116 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.50 to $7.68 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. F2 · ownership.nature: The securities to which this filing relates are held directly by Lynx1 Master Fund LP to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| October 10, 2025 Filed Oct 10, 2025 22:58 UTC |
Lynx1 Capital Management LP10% owner
Nichols Weston10% owner
|
PurchaseCommon Stock | 277,298 | $7.36 | $2,041,384.69 |
DisclosureSEC source: 0000902664-25-004379 · ownership.xml · nonDerivative · entry 3 Lynx1 Capital Management LP · CIK 0001910456 · 10% owner Nichols Weston · CIK 0001746376 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 8,549,084 F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.87 to $7.46 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. F2 · ownership.nature: The securities to which this filing relates are held directly by Lynx1 Master Fund LP to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| October 09, 2025 Filed Oct 10, 2025 22:58 UTC |
Lynx1 Capital Management LP10% owner
Nichols Weston10% owner
|
PurchaseCommon Stock | 626,043 | $6.70 | $4,191,858.72 |
DisclosureSEC source: 0000902664-25-004379 · ownership.xml · nonDerivative · entry 2 Lynx1 Capital Management LP · CIK 0001910456 · 10% owner Nichols Weston · CIK 0001746376 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 8,271,786 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.60 to $6.90 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. F2 · ownership.nature: The securities to which this filing relates are held directly by Lynx1 Master Fund LP to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| October 08, 2025 Filed Oct 10, 2025 22:58 UTC |
Lynx1 Capital Management LP10% owner
Nichols Weston10% owner
|
PurchaseCommon stock, $0.0001 par value per share ("Common Stock") | 556,300 | $6.46 | $3,593,698.00 |
DisclosureSEC source: 0000902664-25-004379 · ownership.xml · nonDerivative · entry 1 Lynx1 Capital Management LP · CIK 0001910456 · 10% owner Nichols Weston · CIK 0001746376 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 7,645,743 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.40 to $6.60 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. F2 · ownership.nature: The securities to which this filing relates are held directly by Lynx1 Master Fund LP to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| August 07, 2025 Filed Aug 8, 2025 21:30 UTC |
Allen Andrew RDirector
|
GrantStock Option (Right to Buy) · Derivative | 79,456 | $0.00 Strike: $7.03 | $0.00 |
DisclosureSEC source: 0000950170-25-106029 · ownership.xml · derivative · entry 1 Allen Andrew R · CIK 0001374539 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,456 Underlying: Common Stock · 79,456 shares Expires 2035-08-07 F1 · derivative.exercise_date: The option represents a right to purchase a total of 79,456 shares of the Issuer's common stock, which shall vest as to one-third of the shares underlying the option on each of the first, second and third anniversaries of the grant date of the award, subject to the Reporting Person's continued service as a director on each such vesting date. Read SEC document |
| August 07, 2025 Filed Aug 8, 2025 21:30 UTC |
Doyle MittieDirector
|
GrantStock Option (Right to Buy) · Derivative | 79,456 | $0.00 Strike: $7.03 | $0.00 |
DisclosureSEC source: 0000950170-25-106028 · ownership.xml · derivative · entry 1 Doyle Mittie · CIK 0001918845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,456 Underlying: Common Stock · 79,456 shares Expires 2035-08-07 F1 · derivative.exercise_date: The option represents a right to purchase a total of 79,456 shares of the Issuer's common stock, which shall vest as to one-third of the shares underlying the option on each of the first, second and third anniversaries of the grant date of the award, subject to the Reporting Person's continued service as a director on each such vesting date. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:12 UTC |
Rosenberg AnthonyDirector
|
GrantStock Option (Right to Buy) · Derivative | 38,513 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0000950170-25-086732 · ownership.xml · derivative · entry 1 Rosenberg Anthony · CIK 0001466175 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,513 Underlying: Common Stock · 38,513 shares Expires 2035-06-12 F1 · derivative.exercise_date: The option represents a right to purchase a total of 38,513 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 12, 2026 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:10 UTC |
Webster Stephen WDirector
|
GrantStock Option (Right to Buy) · Derivative | 38,513 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0000950170-25-086726 · ownership.xml · derivative · entry 1 Webster Stephen W · CIK 0001438421 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,513 Underlying: Common Stock · 38,513 shares Expires 2035-06-12 F1 · derivative.exercise_date: The option represents a right to purchase a total of 38,513 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 12, 2026 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:09 UTC |
Meek David D.Director
|
GrantStock Option (Right to Buy) · Derivative | 38,513 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0000950170-25-086721 · ownership.xml · derivative · entry 1 Meek David D. · CIK 0001555337 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,513 Underlying: Common Stock · 38,513 shares Expires 2035-06-12 F1 · derivative.exercise_date: The option represents a right to purchase a total of 38,513 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 12, 2026 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:14 UTC |
Ryan David P.Director
|
GrantStock Option (Right to Buy) · Derivative | 38,513 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0000950170-25-086737 · ownership.xml · derivative · entry 1 Ryan David P. · CIK 0001951490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,513 Underlying: Common Stock · 38,513 shares Expires 2035-06-12 F1 · derivative.exercise_date: The option represents a right to purchase a total of 38,513 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 12, 2026 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:07 UTC |
Martin Anne-MarieDirector
|
GrantStock Option (Right to Buy) · Derivative | 38,513 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0000950170-25-086718 · ownership.xml · derivative · entry 1 Martin Anne-Marie · CIK 0001914495 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,513 Underlying: Common Stock · 38,513 shares Expires 2035-06-12 F1 · derivative.exercise_date: The option represents a right to purchase a total of 38,513 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 12, 2026 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:00 UTC |
AHMED NADIMDirector · President and CEO
|
SaleCommon Stock | 12,529 | $8.53 | $106,872.37 |
DisclosureSEC source: 0000950170-25-029199 · ownership.xml · nonDerivative · entry 1 AHMED NADIM · CIK 0001731193 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430,621 F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:00 UTC |
Jones Jeffrey AlanChief Medical Officer
|
SaleCommon Stock | 4,895 | $8.53 | $41,754.35 |
DisclosureSEC source: 0000950170-25-029201 · ownership.xml · nonDerivative · entry 1 Jones Jeffrey Alan · CIK 0001914647 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,164 F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:00 UTC |
Michaelson JenniferChief Scientific Officer
|
SaleCommon Stock | 3,756 | $8.53 | $32,038.68 |
DisclosureSEC source: 0000950170-25-029200 · ownership.xml · nonDerivative · entry 1 Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,004 F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:00 UTC |
SUMER JACQUELYN LChief Legal Officer
|
SaleCommon Stock | 3,756 | $8.53 | $32,038.68 |
DisclosureSEC source: 0000950170-25-029197 · ownership.xml · nonDerivative · entry 1 SUMER JACQUELYN L · CIK 0001844824 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,895 F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 23:00 UTC |
Fenton Mary KayChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 120,000 | $0.00 Strike: $9.43 | $0.00 |
DisclosureSEC source: 0000950170-25-025027 · ownership.xml · derivative · entry 2 Fenton Mary Kay · CIK 0001378589 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2035-02-19 F2 · derivative.exercise_date: The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 23:00 UTC |
Fenton Mary KayChief Financial Officer
|
GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-025027 · ownership.xml · nonDerivative · entry 1 Fenton Mary Kay · CIK 0001378589 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 F1 · shares: The shares underlying the restricted stock unit vest on an annual basis over four years. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 23:00 UTC |
AHMED NADIMDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 360,000 | $0.00 Strike: $9.43 | $0.00 |
DisclosureSEC source: 0000950170-25-025029 · ownership.xml · derivative · entry 2 AHMED NADIM · CIK 0001731193 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 360,000 Underlying: Common Stock · 360,000 shares Expires 2035-02-19 F2 · derivative.exercise_date: The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 23:00 UTC |
AHMED NADIMDirector · President and CEO
|
GrantCommon Stock | 180,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-025029 · ownership.xml · nonDerivative · entry 1 AHMED NADIM · CIK 0001731193 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 443,150 F1 · shares: The shares underlying the restricted stock unit vest on an annual basis over four years. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 23:00 UTC |
SUMER JACQUELYN LChief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $9.43 | $0.00 |
DisclosureSEC source: 0000950170-25-025030 · ownership.xml · derivative · entry 2 SUMER JACQUELYN L · CIK 0001844824 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-02-19 F2 · derivative.exercise_date: The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 23:00 UTC |
SUMER JACQUELYN LChief Legal Officer
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-025030 · ownership.xml · nonDerivative · entry 1 SUMER JACQUELYN L · CIK 0001844824 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,651 F1 · shares: The shares underlying the restricted stock unit vest on an annual basis over four years. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 23:00 UTC |
Michaelson JenniferChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $9.43 | $0.00 |
DisclosureSEC source: 0000950170-25-025032 · ownership.xml · derivative · entry 2 Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-02-19 F2 · derivative.exercise_date: The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 23:00 UTC |
Michaelson JenniferChief Scientific Officer
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-025032 · ownership.xml · nonDerivative · entry 1 Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,760 F1 · shares: The shares underlying the restricted stock unit vest on an annual basis over four years. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 23:00 UTC |
Savill CorrineChief Business Officer
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $9.43 | $0.00 |
DisclosureSEC source: 0000950170-25-025031 · ownership.xml · derivative · entry 2 Savill Corrine · CIK 0001837524 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2035-02-19 F2 · derivative.exercise_date: The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 23:00 UTC |
Savill CorrineChief Business Officer
|
GrantCommon Stock | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-025031 · ownership.xml · nonDerivative · entry 1 Savill Corrine · CIK 0001837524 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,990 F1 · shares: The shares underlying the restricted stock unit vest on an annual basis over four years. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 23:00 UTC |
Jones Jeffrey AlanChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 130,000 | $0.00 Strike: $9.43 | $0.00 |
DisclosureSEC source: 0000950170-25-025028 · ownership.xml · derivative · entry 2 Jones Jeffrey Alan · CIK 0001914647 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2035-02-19 F2 · derivative.exercise_date: The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 23:00 UTC |
Jones Jeffrey AlanChief Medical Officer
|
GrantCommon Stock | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-025028 · ownership.xml · nonDerivative · entry 1 Jones Jeffrey Alan · CIK 0001914647 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,059 F1 · shares: The shares underlying the restricted stock unit vest on an annual basis over four years. Read SEC document |
| January 06, 2025 Filed Jan 7, 2025 22:00 UTC |
Michaelson JenniferChief Scientific Officer
|
SaleCommon Stock | 4,000 | $12.51 | $50,040.00 |
DisclosureSEC source: 0000950170-25-002946 · ownership.xml · nonDerivative · entry 1 Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,760 F1 · kind: Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on January 5, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.32 to $12.62. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| December 24, 2024 Filed Dec 27, 2024 23:00 UTC |
AHMED NADIMDirector · President and CEO
|
SaleCommon Stock | 8,400 | $11.87 | $99,708.00 |
DisclosureSEC source: 0000950170-24-140856 · ownership.xml · nonDerivative · entry 1 AHMED NADIM · CIK 0001731193 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 263,150 F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units. Read SEC document |
| December 18, 2024 Filed Dec 20, 2024 22:00 UTC |
Michaelson JenniferChief Scientific Officer
|
SaleCommon Stock | 4,693 | $11.41 | $53,547.13 |
DisclosureSEC source: 0000950170-24-139125 · ownership.xml · nonDerivative · entry 1 Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,760 F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units. Read SEC document |
| December 18, 2024 Filed Dec 20, 2024 22:00 UTC |
Jones Jeffrey AlanChief Medical Officer
|
SaleCommon Stock | 4,632 | $11.41 | $52,851.12 |
DisclosureSEC source: 0000950170-24-139124 · ownership.xml · nonDerivative · entry 1 Jones Jeffrey Alan · CIK 0001914647 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,059 F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units. Read SEC document |
| December 18, 2024 Filed Dec 20, 2024 22:00 UTC |
SUMER JACQUELYN LChief Legal Officer
|
SaleCommon Stock | 3,482 | $11.41 | $39,729.62 |
DisclosureSEC source: 0000950170-24-139123 · ownership.xml · nonDerivative · entry 1 SUMER JACQUELYN L · CIK 0001844824 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,651 F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 22:00 UTC |
Michaelson JenniferChief Scientific Officer
|
SaleCommon Stock | 3,489 | $12.52 | $43,682.28 |
DisclosureSEC source: 0000950170-24-136726 · ownership.xml · nonDerivative · entry 1 Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,453 F1 · kind: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 22:30 UTC |
Michaelson JenniferChief Scientific Officer
|
SaleCommon Stock | 8,000 | $15.64 | $125,120.00 |
DisclosureSEC source: 0000950170-24-123538 · ownership.xml · nonDerivative · entry 1 Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,942 F1 · kind: Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on January 5, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.25 to $15.98. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 21:30 UTC |
Michaelson JenniferChief Scientific Officer
|
SaleCommon Stock | 8,000 | $18.09 | $144,720.00 |
DisclosureSEC source: 0000950170-24-104820 · ownership.xml · nonDerivative · entry 1 Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,942 F1 · kind: Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on January 5, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.79 to $18.55. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 08, 2024 Filed Aug 9, 2024 21:00 UTC |
Thistle MaryDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,743 | $0.00 Strike: $16.38 | $0.00 |
DisclosureSEC source: 0000950170-24-094861 · ownership.xml · derivative · entry 1 Thistle Mary · CIK 0001317917 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,743 Underlying: Common Stock · 25,743 shares Expires 2034-08-08 F1 · derivative.exercise_date: The option represents a right to purchase a total of 25,743 shares of the Issuer's common stock, which shall vest as to one-third of the shares underlying the option on each of the first, second and third anniversaries of the grant date of the award, subject to the Reporting Person's continued service as a director on each such vesting date. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 21:30 UTC |
Michaelson JenniferChief Scientific Officer
|
SaleCommon Stock | 8,000 | $16.33 | $130,640.00 |
DisclosureSEC source: 0000950170-24-082485 · ownership.xml · nonDerivative · entry 1 Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 123,942 F1 · kind: Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on January 5, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.97 to $16.77. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 23:30 UTC |
Michaelson JenniferChief Scientific Officer
|
GrantCommon Stock | 2,360 | $9.00 | $21,240.00 |
DisclosureSEC source: 0000950170-24-080961 · ownership.xml · nonDerivative · entry 1 Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,942 F2 · price: In accordance with the ESPP, the shares were purchased based on 85% of the closing price of the Issuer's common stock on January 2, 2024. F1 · acquired: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2021 Employee Stock Purchase Plan (the "ESPP"), for the purchase period of January 1, 2024 through June 30, 2024. This transaction is also exempt under Rule 16b-3(c). Read SEC document |
| June 26, 2024 Filed Jun 27, 2024 23:00 UTC |
Rosenberg AnthonyDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,806 | $0.00 Strike: $16.50 | $0.00 |
DisclosureSEC source: 0000950170-24-078677 · ownership.xml · derivative · entry 1 Rosenberg Anthony · CIK 0001466175 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,806 Underlying: Common Stock · 15,806 shares Expires 2034-06-26 F1 · derivative.exercise_date: The option represents a right to purchase a total of 15,806 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 26, 2025 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.